Future Relationships

The current portfolio has been selected to be attractive to partnerships, addressing major unmet needs and further information on specific partnership opportunities should at first be addressed to:
info@immbio.com

As both technology platforms have broad utility, ImmBio would consider entering into discussions on the potential fit across the anti-infective landscape, where there is a strong rationale on the utility of the technology platform.